Year |
Citation |
Score |
2016 |
Martin LD, Harizanova J, Mai S, Belch AR, Pilarski LM. FGFR3 preferentially colocalizes with IGH in the interphase nucleus of multiple myeloma patient B-cells when FGFR3 is located outside of CT4. Genes, Chromosomes & Cancer. PMID 27509849 DOI: 10.1002/Gcc.22394 |
0.609 |
|
2013 |
Martin LD, Harizanova J, Righolt CH, Zhu G, Mai S, Belch AR, Pilarski LM. Differential nuclear organization of translocation-prone genes in nonmalignant B cells from patients with t(14;16) as compared with t(4;14) or t(11;14) myeloma. Genes, Chromosomes & Cancer. 52: 523-37. PMID 23460268 DOI: 10.1002/Gcc.22049 |
0.52 |
|
2012 |
Martin LD, Harizanova J, Zhu G, Righolt CH, Belch AR, Mai S, Pilarski LM. Differential positioning and close spatial proximity of translocation-prone genes in nonmalignant B-cells from multiple myeloma patients. Genes, Chromosomes & Cancer. 51: 727-42. PMID 22489023 DOI: 10.1002/Gcc.21959 |
0.62 |
|
2010 |
Martin LD, Belch AR, Pilarski LM. Promiscuity of translocation partners in multiple myeloma. Journal of Cellular Biochemistry. 109: 1085-94. PMID 20127714 DOI: 10.1002/jcb.22499 |
0.57 |
|
2010 |
Martin LD, Harizanova J, Zhu G, Belch A, Mai S, Pilarski LM. Cancer-Specific Nuclear Positioning of Translocation Prone Gene Loci In Non-Malignant B-Cells From Patients with Multiple Myeloma Blood. 116: 783-783. DOI: 10.1182/Blood.V116.21.783.783 |
0.618 |
|
2008 |
Kirshner J, Thulien KJ, Martin LD, Debes Marun C, Reiman T, Belch AR, Pilarski LM. A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma. Blood. 112: 2935-45. PMID 18535198 DOI: 10.1182/Blood-2008-02-142430 |
0.567 |
|
2007 |
Kirshner J, Thulien KJ, Martin LD, Marun CD, Reiman T, Belch AR, Pilarski LM. A Unique Pre-Clinical Model Providing Access to a Drug Resistant Population within the Multiple Myeloma Stem Cell Niche in a Novel 3-D Culture System for Bone Marrow. Blood. 110: 547-547. DOI: 10.1182/Blood.V110.11.547.547 |
0.547 |
|
Show low-probability matches. |